Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
Bryan Garnier today reaffirms its buy investment rating on AstraZeneca PLC (LON:AZN) and raised its price target to 9100p (from 8780p).
Broker Forecasts data provided by www.sharesmagazine.co.uk